NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
74 hedge funds and large institutions have $61M invested in Northwest Biotherapeutics, Inc. Common stock in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 31 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
51% less capital invested
Capital invested by funds: $124M → $61M (-$63.1M)
Holders
74
Holding in Top 10
1
Calls
$354K
Puts
$669K
Top Buyers
| 1 | +$3.5M | |
| 2 | +$654K | |
| 3 | +$344K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$227K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$189K |
Top Sellers
| 1 | -$653K | |
| 2 | -$184K | |
| 3 | -$123K | |
| 4 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$96K |
| 5 |
Millennium Management
New York
|
-$78K |